Recent Searches
Rubi is an experienced Director in the EY-Parthenon Strategy team. She focuses on the life sciences industry, supporting corporate clients as well as PE firms in strategy and transaction topics.
She has broad experience in strategy consulting, with a successful track record supporting pharma, biotech, medtech firms, CDMOs, consumer healthcare players, as well as investors in topics related to corporate and growth strategy, market access and assessments, portfolio strategy, operations optimization, commercial due diligences, carve-outs as well as in- and out-licensing.
Rubi continuously makes a positive impact for her clients, supporting them to develop winning strategies, navigate challenges, execute transactions and achieve growth in the life sciences industry.
Through a strategic lens and hands-on experience craving strategies and supporting transactions in the life sciences arena, Rubi successfully supports companies and investors to achieve their strategic goals, optimize their market play, form alliances and navigate an increasingly complex environment. She teams up globally to bring the best of EY to her clients and seamlessly team across the globe, to maximize impact.
Rubi has broad experience on life sciences and has authored several publications and reports on relevant topics for (Bio)pharma, CDMOs, investors and the entire industry ecosystem.
